Frontlight ResearchEarly access
Trial site
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Thyroid cancer1 trial
- Phase
- Phase 33 trials
- Phase 12 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer3 trials
- Bristol-Myers Squibb1 trial
- Eli Lilly and Company1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026